Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from Pfizer

Why Shares Of Valneva SE Are Soaring Today

Valneva SE (NASDAQ: VALN) shares are trading higher after the company and Pfizer announced they have entered into an Equity Subscription Agreement and have updated the terms of their Collaboration and License Agreement for Lyme disease vaccine candidate VLA15.

Benzinga

The Daily Biotech Pulse: Thumbs Down For Acadia's Pimavanserin, Pfizer Buys Stake In Valneva, AstraZeneca - Ionis Eplontersen Aces Rare Disease Trial

Here's a roundup of top developments in the biotech space over the last 24 hours:

Benzinga

Editorial: On kids’ vaccines, DeSantis is wrong, but never in doubt

The quip “often wrong, never in doubt” fits Gov. Ron DeSantis like a glove. He takes it to extremes by doubling down, at the expense of our children, on his cultivated political appeal to the anti-vaxxer element of right-wing America.

Tribune News Service

From analysis to the latest developments in health,
read the most diverse news in one place.

Shots for tots: COVID vaccinations start for little US kids

The nation’s youngest children are getting their chance at vaccines for COVID-19

The Independent UK

Chicago gears up to vaccinate kids under 5 against COVID-19 following federal authorization

From how to prepare your kids to where to get vaccinated, the Sun-Times answers parents’ questions.

Chicago Sun-Times

What you need to know about COVID vaccines for kids under 5

COVID-19 vaccines for children under 5 years old were authorized by the U.S. Food and Drug Administration on Friday and by the Centers for Disease Control and Prevention on Saturday, a welcome relief to parents of the last age group to become eligible for shots.

Tribune News Service

Mass. governor's administration approves COVID vaccines for young kids after CDC OK

BOSTON — Parent’s of very young children received some good news from the Baker administration Sunday, when the state announced COVID-19 vaccines would become available Tuesday.

Boston Herald

Read news from The Economist, FT, and more,
with one subscription

Youngest kids in US cleared for Moderna, Pfizer COVID vaccines

U.S. health officials approved COVID-19 vaccines for infants and toddlers, the last remaining age group that hasn’t been eligible for inoculation.

Tribune News Service

Doctors ‘thrilled’ to order COVID vaccines for young kids after DeSantis changes course

MIAMI — Pediatricians across Florida have begun ordering COVID-19 vaccines for their patients under 5 after Gov. Ron DeSantis changed course Friday and allowed doctors and hospitals in the state to get them from a federal program.

Miami Herald

COVID shots for infants, preschoolers OKed to begin in the coming week

The approval Saturday from Dr. Rochelle Walensky, the CDC’s director. expands the nation’s coronavirus vaccination campaign to children as young as 6 months old.

Chicago Sun-Times

US panel backs Moderna, Pfizer COVID shots for youngest kids

Infants and toddlers in the U.S. are now able to be vaccinated against COVID-19 after shots from Moderna Inc. and Pfizer Inc. won support from health advisers on Saturday.

Tribune News Service

Kids under 5 can get COVID vaccines next week after CDC approval

CDC Director Walensky has agreed with the recommendation the Moderna and Pfizer shots be given to children as young as six months old.

Axios

CDC clears the way for vaccinations for children 6 months to 5 years old

CDC advisers are recommending the use of two separate COVID-19 vaccines for the youngest children made by Moderna and Pfizer-BioNTech, paving the way for vaccine rollout as early as next week.

WEKU

CDC recommends Covid vaccines for infants, toddlers and preschoolers

Children as young as six months will be able to get shots from either Pfizer or Moderna after Friday’s FDA approval

The Guardian - US

Get all your
news in one place.

100's of premium titles.
One news app.

The Independent UK

CDC advisers recommend COVID-19 shots for children under 5

U.S. health advisers have recommended COVID-19 vaccines for infants, toddlers and preschoolers — the last group without the shots

Tribune News Service

Editorial: Gov. DeSantis’ hypocrisy on parental rights

Is there anyone’s life Ron DeSantis won’t endanger in his anticipated run for the White House?

Chicago Sun-Times

FDA approves COVID-19 shots for children under 5

U.S. kids under 5 — roughly 18 million youngsters — are eligible for the shots.

WEKU

The FDA authorizes COVID-19 shots for infants and preschoolers

The vaccinations for children as young as 6 months old could start next week. But first, the Centers for Disease Control and Prevention must sign off.

Get all your
news in one place.

100's of premium titles.
One news app.

Tribune News Service

With COVID shots approved for toddlers, here’s what you need to know

The U.S. Food and Drug Administration authorized COVID-19 vaccines for children under 5 years old Friday, a welcome relief to parents of the last age group to become eligible for shots. Although the move will help protect children from infection and serious disease, vaccine hesitancy still looms in the U.S.…

Al Jazeera

US: FDA authorises COVID-19 vaccines for children under 5

President Joe Biden says jabs could be rolled out to that age group as early as next week, pending CDC recommendations.

The Guardian - AU

Covid vaccines may soon be approved for young children in the US – will Australia do the same?

Moderna and Pfizer vaccine trials for children six months to five years old look promising and experts say the TGA is likely to approve both

The Conversation

At last, COVID-19 shots for little kids – 5 essential reads

For many parents of kids under age 5, a safe and effective COVID-19 vaccine could not come soon enough. A full year and a half after shots first became available for adults, their wait is nearly over.

Benzinga

BMO Capital Says Risk/Reward For This Gene Stock Assumes Clinical Success

BMO Capital initiated coverage on Beam Therapeutics Inc (NASDAQ:BEAM) with a Market Perform rating and a price target of 41. BMO writes that it appreciates the high potential of Beam's next-generation editing approach, but clinical validation is yet to be established. Preclinical base editing data point to a favorable benefit/risk profile. Also Read: Pfizer, Beam…

Benzinga

Pfizer-BioNTech COVID-19 Vaccine Receives FDA Emergency Use Nod For Kids As Young As Six Months

The FDA has granted emergency use authorization (EUA) to Pfizer Inc (NYSE:PFE) and BioNTech SE's (NASDAQ:BNTX) COVID-19 Vaccine as a three 3-µg dose series for children six months through 4 years of age. Based on safety, tolerability, and immunogenicity data, the 3-µg dose was carefully selected as the preferred dose for children under five. The EUA…

The Guardian - US

US authorizes first Covid vaccines for infants and preschoolers

FDA’s action follows its advisory panel’s unanimous recommendation for the shots from Moderna and Pfizer

1 … 46 47 48 49

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Food and Drug Administration

336 stories

TGA

319 stories

Centers for Disease Control and Prevention

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.